Back to top
more

ICU Medical (ICUI)

(Delayed Data from NSDQ)

$94.84 USD

94.84
81,315

+0.31 (0.33%)

Updated Apr 26, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for ICUI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

ICU Medical, Inc. [ICUI]

Reports for Purchase

Showing records 141 - 160 ( 291 total )

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 141

09/05/2018

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 142

09/04/2018

Daily Note

Pages: 5

Another Three-Day Weekend, Another Leaked Media Report

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 143

08/10/2018

Daily Note

Pages: 11

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 144

08/09/2018

Company Report

Pages: 7

Another Step Forward for the Margins

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 145

07/24/2018

Daily Note

Pages: 15

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 146

07/23/2018

Company Report

Pages: 8

Assumptions Not Changing Much; Price Paid Could Be Lower

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 147

05/29/2018

Daily Note

Pages: 3

Timing Not Great, but Doable and Potentially Fairly Accretive

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 148

05/29/2018

Daily Note

Pages: 6

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 149

05/09/2018

Company Report

Pages: 7

Incremental Positives Emerge Beyond Its Typical Sales and EBITDA Beats

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 150

05/01/2018

Company Report

Pages: 2

Termination of Sell Side Coverage - Buy

Provider: G.RESEARCH, LLC

Analyst: TSAI J

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 151

03/05/2018

Company Report

Pages: 2

4Q 2017 Results - Buy

Provider: G.RESEARCH, LLC

Analyst: TSAI J

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 152

03/02/2018

Daily Note

Pages: 11

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 153

03/01/2018

Company Report

Pages: 7

Hospira Integration and Turnaround Well Under Control

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 154

02/26/2018

Company Report

Pages: 7

One Flu Over the Cuckoo’s Nest

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 155

02/26/2018

Daily Note

Pages: 9

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 156

01/18/2018

Daily Note

Pages: 7

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 157

01/17/2018

Daily Note

Pages: 9

Medical Products: 4Q Earnings Preview; Positive Momentum and Trying to Avoid a Sell the News

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 158

01/15/2018

Daily Note

Pages: 6

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 159

11/13/2017

Company Report

Pages: 2

3Q 2017 Results - Buy

Provider: G.RESEARCH, LLC

Analyst: TSAI J

Price: 10.00

Research Provided by a Third Party

Company: ICU Medical, Inc.

Industry: Medical - Products

Record: 160

11/10/2017

Company Report

Pages: 7

Integration Progressing Well; LT Opportunity in IV Solutions Most Important

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party